SLAMF7: SLAM family member 7
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family.
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Elotuzumab | Approved | SLAM family member 7 inhibitor | Inhibitor | — |
| Azintuxizumab vedotin | — | SLAM family member 7 binding agent | Binding agent | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Plasma cell myeloma
- 0.60
- Neoplasm
- 0.40
- Rotator cuff syndrome
- 0.24
- Delayed puberty
- 0.20
- Abnormality of the skeletal system
- 0.19
- Miyoshi myopathy
- 0.11
- Autism
- 0.11
- AL amyloidosis
- 0.10
- Breast cancer
- 0.09
Drugs and mechanisms are from ChEMBL CHEMBL3559386 (CC BY-SA 3.0). Gene name, function (UniProt Q9NQ25, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets